GWS
ORGO icon

Greykasell Wealth Strategies’s Organogenesis Holdings ORGO Stock Holding History

Greykasell Wealth Strategies’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,700
Closed -$7.34K – 337
2025
Q1 		$7.34K Buy
+1,700
New +$6.86K ﹤0.01% 276

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greykasell Wealth Strategies's ORGO Position: Q2 2025 in Review

Greykasell Wealth Strategies sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 1,700 shares — an estimated $7.34K sold.

Greykasell Wealth Strategies first reported a position in ORGO in Q1 2025 and held it in 1 quarter. The position peaked at $7.34K in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Greykasell Wealth Strategies reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Greykasell Wealth Strategies sold 1,700 Organogenesis Holdings shares in Q2 2025, an estimated $7.34K.
  • Greykasell Wealth Strategies first reported a position in Organogenesis Holdings in Q1 2025 and held it in 1 quarter.
  • Greykasell Wealth Strategies's Organogenesis Holdings position peaked at $7.34K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2025, filed 11 Aug 2025.